2024-09-17
08:46 |
|
|
Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients Actualización de las recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (COVID-19) en pacientes con trasplante renal
/
López, V. (Hospital Regional Universitario de Málaga) ;
Mazuecos, A. (Hospital Universitario Puerta del Mar) ;
Villanego, F. (Hospital Universitario Puerta del Mar) ;
López-Oliva, M. (Hospital La Paz) ;
Alonso, A. (Complejo Hospitalario A Coruña) ;
Beneyto, I. (Hospital Universitario Politécnico La Fe) ;
Crespo, Marta (Hospital del Mar (Barcelona, Catalunya)) ;
Díaz-Corte, C. (Hospital Universitario Central de Asturias) ;
Franco, A. (Hospital de Alicante) ;
González-Roncero, F. (Hospital Virgen del Rocío) ;
Guirado, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Jiménez, C. (Hospital La Paz) ;
Juega, Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Llorente, S. (Hospital Universitario Virgen de la Arrixaca (Múrcia)) ;
Paul, J. (Hospital Miguel Servet) ;
Rodríguez-Benot, A. (Hospital Reina Sofía) ;
Ruiz, J. C. (Hospital Marqués de Valdecilla) ;
Sánchez-Fructuoso, A. (Hospital Clínico San Carlos) ;
Torregrosa, Vicente (Hospital Clínic i Provincial de Barcelona) ;
Zárraga, S. (Hospital de Cruces) ;
Rodrigo, E. (Hospital Marqués de Valdecilla) ;
Hernández, D. (Universidad de Málaga) ;
Universitat Autònoma de Barcelona
SARS-CoV-2 infection (COVID-19) has had a significant impact on transplant activity in our country. Mortality and the risk of complications associated with COVID-19 in kidney transplant (KT) recipients were expected to be higher due to their immunosuppressed condition and the frequent associated comorbidities. [...]
2023 -  10.1016/j.nefro.2022.11.001
Nefrología (Badalona. English), Vol. 43 Núm. 5 (enero 2023) , p. 531-545
|
|
2024-09-06
12:14 |
|
2024-09-05
10:21 |
|
11 p, 519.7 KB |
Early intervention in psoriasis and immune-mediated inflammatory diseases : A hypothesis paper
/
Girolomoni, G. (University of Verona) ;
Griffiths, C.E.M. (University of Manchester) ;
Krueger, J. (Rockefeller University) ;
Nestle, F.O. (King's College London) ;
Nicolas, J.F. (University of Lyon) ;
Prinz, J.C. (University of Munich) ;
Puig, Lluís (Institut d'Investigació Biomèdica Sant Pau) ;
Ståhle, M. (Karolinska Institutet) ;
Van De Kerkhof, P.C.M. (Nijmegen Medical Centre) ;
Allez, M. (Universite Denis Diderot Paris) ;
Emery, P. (Leeds Teaching Hospitals (Regne Unit)) ;
Paul, C. (Paul Sabatier University (Tolosa)) ;
Universitat Autònoma de Barcelona
Departament de Medicina
Psoriasis is an immune-mediated inflammatory disease (IMID) which may have a major impact on a patient's life, especially when the disease is moderate to severe. There is evidence that treatment of psoriasis during the first years is conservative and frequently based on topical agents which rarely clear lesions. [...]
2015 - 10.3109/09546634.2014.880396
Journal of Dermatological Treatment, Vol. 26 Núm. 2 (january 2015) , p. 103-112
|
|
2024-09-05
10:21 |
|
7 p, 179.6 KB |
Preventive treatments for breast cancer : recent developments
/
Alés-Martínez, José Enrique (Hospital Nuestra Señora de Sonsoles (Àvila)) ;
Ruiz, Amparo (Instituto Valenciano de Oncología) ;
Chacón, José Ignacio (Hospital Virgen de la Salud (Toledo)) ;
Lluch Hernández, A. (Hospital Clínic Universitari (València)) ;
Ramos Vázquez, Manuel (Centro Oncológico de Galicia) ;
Córdoba, Octavi (Hospital Universitari Vall d'Hebron) ;
Aguirre, Elena (Hospital Arnau de Vilanova (Lleida, Catalunya)) ;
Barnadas Molins, Agustí (Institut d'Investigació Biomèdica Sant Pau) ;
Jara Sánchez, Carlos (Hospital Universitario Fundación Alcorcón) ;
González Santiago, Santiago (Hospital San Pedro de Alcántara) ;
Plazaola, A. (Onkologikoa (Guipúscoa)) ;
Florián, Jesús (Hospital de Barbastro (Osca)) ;
Andrés Conejero, Raquel (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Sánchez Rovira, Pedro (Complejo Hospitalario de Jaén) ;
Frau, Adolfo (Hospital Provincial de Castellón) ;
Universitat Autònoma de Barcelona
Departament de Medicina
Breast cancer is a burden for western societies, and an increasing one in emerging economies, because of its high incidence and enormous psychological, social, sanitary and economic costs. However, breast cancer is a preventable disease in a significant proportion. [...]
2015 - 10.1007/s12094-014-1250-2
Clinical & translational oncology, Vol. 17 Núm. 4 (13 2015) , p. 257-263
|
|
2024-09-05
10:21 |
|
2024-09-05
10:21 |
|
6 p, 519.6 KB |
Controversies in the treatment of invasive urothelial carcinoma : A case report and review of the literature Urological oncology
/
Guillem, Vicente (Fundació Institut Valencià d'Oncologia) ;
Climent, Miguel Ángel (Fundació Institut Valencià d'Oncologia) ;
Cassinello, Javier (Hospital Universitario de Guadalajara) ;
Esteban, Emilio (Hospital Universitario Central de Asturias) ;
Castellano, Daniel (Hospital Universitario 12 de Octubre (Madrid)) ;
González-Larriba, José Luis (Hospital Clínico San Carlos (Madrid)) ;
Maroto, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Camps, Carlos (Universitat de València) ;
Universitat Autònoma de Barcelona
Background: More than 429,000 patients worldwide are diagnosed with bladder cancer each year and muscle-invasive bladder cancer has an especially poor outcome. The median age at diagnosis is over 70 years, and many patients also have a substantial number of age-associated impairments that need to be considered when planning therapeutic interventions. [...]
2015 - 10.1186/s12894-015-0008-7
BMC Urology, Vol. 15 Núm. 1 (december 2015) , p. 15
|
|
2024-09-03
09:12 |
|
2024-09-01
18:06 |
|
29 p, 3.3 MB |
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
/
van Doorn, Pieter (University Medical Center (Països Baixos)) ;
Van den Bergh, Peter (University Hospital Saint-Luc (Bèlgica)) ;
Hadden, Robert (King's College Hospital (Regne Unit)) ;
Avau, Bert (CEBaP. Belgian Red Cross (Bèlgica)) ;
Vankrunkelsven, Patrick (Cochrane Belgium (Bèlgica)) ;
Attarian, Sharam (Centre de Référence des Maladies Neuromusculaires et de la SLA (França)) ;
Blomkwist-Markens, Patricia H. (Patient Representative GBS/CIDP Foundation International (Estats Units d'Amèrica)) ;
Cornblath, David Reid (Johns Hopkins University School of Medicine (Xina)) ;
Goedee, Hendrik Stephan (University Medical Center Utrecht (Països Baixos)) ;
Harbo, Thomas (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Jacobs, Bart C (University Medical Center (Països Baixos)) ;
Kusunoki, Susumu (Kindai University (Japó)) ;
Lehmann, Helmar Christoph (University Hospital Köln (Alemanya)) ;
Lewis, Richard Alan (Cedars-Sinai Medical Center (Estats Units d'Amèrica)) ;
Lunn, Michael P. (National Hospital for Neurology and Neurosurgery (Regne Unit)) ;
Nobile-Orazio, Eduardo (University of Milan (Itàlia)) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Rajabally, Yusuf Ali (Queen Elizabeth Hospital Birmingham (Regne Unit)) ;
Umapathi, Thirugnanam N. (National Neuroscience Institute (Singapur)) ;
Topaloglu, Haluk A. (Yeditepe University (Turquia)) ;
Willison, Hugh John (University of Glasgow (Escòcia)) ;
Universitat Autònoma de Barcelona
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic dysfunction and pain. [...]
2023 - 10.1111/jns.12594
Journal of the Peripheral Nervous System, Vol. 28 Núm. 4 (december 2023) , p. 535-563
|
|
2024-09-01
18:06 |
|
29 p, 3.3 MB |
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome
/
van Doorn, Pieter (University Medical Center (Països Baixos)) ;
Van den Bergh, Peter (University Hospital Saint-Luc (Bèlgica)) ;
Hadden, Robert (King's College Hospital (Regne Unit)) ;
Avau, Bert (CEBaP. Belgian Red Cross (Bèlgica)) ;
Vankrunkelsven, Patrick (Cochrane Belgium (Bèlgica)) ;
Attarian, Sharam (CHU Timone (França)) ;
Blomkwist-Markens, Patricia H. (Patient Representative GBS/CIDP Foundation International (Estats Units d'Amèrica)) ;
Cornblath, David Reid (Johns Hopkins University School of Medicine (Xina)) ;
Goedee, Hendrik Stephan (University Medical Center Utrecht (Països Baixos)) ;
Harbo, Thomas (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Jacobs, Bart C (University Medical Center (Països Baixos)) ;
Kusunoki, Susumu (Kindai University (Japó)) ;
Lehmann, Helmar Christoph (University Hospital Köln (Alemanya)) ;
Lewis, Richard Alan (Cedars-Sinai Medical Center(Estats Units d'Amèrica)) ;
Lunn, Michael P. (National Hospital for Neurology and Neurosurgery (Regne Unit)) ;
Nobile-Orazio, Eduardo (University of Milan (Itàlia)) ;
Querol, Luis (Institut d'Investigació Biomèdica Sant Pau) ;
Rajabally, Yusuf Ali (Queen Elizabeth Hospital Birmingham (Regne Unit)) ;
Umapathi, Thirugnanam N. (National Neuroscience Institute(Singapur)) ;
Topaloglu, Haluk A. (Yeditepe University (Turquia)) ;
Willison, Hugh John (University of Glasgow (Escòcia)) ;
Universitat Autònoma de Barcelona
Guillain-Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary greatly in presentation and severity. Besides weakness and sensory disturbances, patients may have cranial nerve involvement, respiratory insufficiency, autonomic dysfunction and pain. [...]
2023 - 10.1111/ene.16073
European Journal of Neurology, Vol. 30 Núm. 12 (december 2023) , p. 3646-3674
|
|
2024-07-30
05:43 |
|
|
|
visitante ::
identificación
Estadísticas de uso
Los más consultados
